Prenatal Antiseizure Medications May Impact Child Development
This study looked at how being exposed to antiseizure medications (ASMs) before birth affects children’s cognitive development from ages 2 to 6.
Pregnancy
This hub covers epilepsy and pregnancy: Seizure control, medication safety, folic acid, and planning before, during, and after pregnancy. Research summaries to support informed decisions.
What you’ll find in this topic:
- Plain-language summaries of new epilepsy studies
- What the research means for real life
- Practical questions to ask your neurologist
- Related topics you can explore next
Epilepsy and Pregnancy: What Families Usually Want to Know
- Planning before pregnancy (the best time to reduce risk)
- Medication safety, seizure control, and why abrupt changes are risky
- Folic acid and prenatal monitoring
- Postpartum: sleep deprivation, meds, and newborn safety planning
Common Pregnancy Terms in Plain English
- Teratogenic risk: chance a medication affects fetal development
- Monotherapy: one medication (often preferred when possible)
- Therapeutic drug monitoring: checking blood levels (levels can shift in pregnancy)
- Preconception counseling: planning visit before pregnancy to optimize meds and safety
- Postpartum risk: seizure risk can change due to sleep loss and hormone shifts
Related Topics
Epilepsy and Pregnancy FAQ
Should I stop my medication if I’m pregnant?
No. Stopping medication suddenly can be dangerous. Medication decisions should be planned with your neurologist/OB.
Why do medication levels change in pregnancy?
Body water, metabolism, and clearance change. Some meds need dose adjustments guided by blood levels.
Do seizures always get worse during pregnancy?
Not always. Many people remain stable, especially with good adherence and monitoring.
What about sleep after the baby arrives?
Sleep deprivation is a real risk. Planning shifts and extra support isn’t “extra,” it’s safety.
-
-
Zika Exposure Linked to Epilepsy Risk in Some Children
A study was conducted in Brazil to understand the relationship between prenatal exposure to the Zika virus and the risk of epilepsy-related hospitalizations in young children.
-
Ivermectin Shows Promise for Treating Infantile Epileptic Spasms
Researchers studied the effects of a drug called EQU-001 (ivermectin) on spasms in a rat model of infantile epileptic spasms syndrome (IESS).
-
Maternal Obesity Linked to Higher Risk of Child Disorders
This study looked at how a mother’s weight before pregnancy affects the development of her child.
-
ART Offers Hope for Women with Epilepsy Seeking Pregnancy
Researchers studied the challenges and outcomes of assisted reproductive technologies (ART) for women with epilepsy (WWE).
-
Child Neurologists Need Better Training on Reproductive Health Counseling
This study looked at how child neurologists talk to female patients with epilepsy about reproductive health.
-
Monitoring Levetiracetam in Pregnancy Needs Standardized Guidelines
Researchers studied how levetiracetam, a common medication for epilepsy, is monitored during pregnancy.
-
SSPOP Gene Mutations Linked to Epilepsy and Developmental Issues
In this study, researchers looked at the SSPOP gene and its connection to epilepsy and developmental disorders in children.
-
Managing Epilepsy in Women During Reproductive Years
This study focused on women with epilepsy who are of childbearing age, a group that faces specific challenges related to their condition and reproductive health.
